Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• The ErbB3 receptor-binding protein EBP1 exists as two isoforms, P48 and P42, with suspected differing roles in cancer.
• The mechanisms underlying these differential roles in tumorigenesis remain largely uncharacterized.

Purpose of the Study:

• To elucidate the distinct molecular mechanisms by which EBP1 isoforms P48 and P42 influence tumorigenesis.
• To investigate the interaction between EBP1 isoforms and the SCF-type ubiquitin ligase FBXW7.

Main Methods:

• Co-immunoprecipitation assays to study protein-protein interactions.
• Subcellular localization studies to assess protein compartmentalization.
• Western blotting to evaluate protein degradation pathways.

Main Results:

• EBP1 P48 binds to the WD domain of FBXW7, acting as an oncogenic substrate that sequesters FBXW7α in the cytosol, thereby inhibiting its tumor suppressor function.
• EBP1 P42 binds to the F-box domain of FBXW7 and its substrates, functioning as an adapter to promote FBXW7-mediated degradation of oncogenic targets and enhance tumor suppression.
• These distinct interactions lead to isoform-specific functions of EBP1 in cancer development.

Conclusions:

• EBP1 isoforms P48 and P42 exhibit opposing roles in tumorigenesis through differential interactions with FBXW7.
• EBP1 P48 promotes cancer by inhibiting FBXW7, while EBP1 P42 suppresses cancer by enhancing FBXW7 activity.
• Understanding these isoform-specific mechanisms provides novel insights into EBP1's role in cancer and potential therapeutic strategies.